Breaking News Instant updates and real-time market news.

ACN

Accenture

$121.52

0.7 (0.58%)

19:49
05/07/17
05/07
19:49
05/07/17
19:49

Accenture says acquires creative agency Monkeys, design business Maud

Accenture announced it has acquired the creative agency The Monkeys and design business, Maud. "The Monkeys is Australia's most awarded independent creative advertising agency, renowned for its brand strategy and creative talent. The move strengthens the customer experience capabilities of Accenture Interactive and demonstrates Accenture's continuing investment in bringing new thinking, talent and innovation to clients across Australia and New Zealand," the company said. Terms of the transaction were not disclosed.

ACN Accenture
$121.52

0.7 (0.58%)

04/03/17
GSCO
04/03/17
DOWNGRADE
Target $110
GSCO
Sell
Accenture downgraded to Sell from Neutral at Goldman
Goldman analyst James Schneider downgraded Accenture to Sell and lowered its price target to $110 from $125 telling investors he expects consulting growth to slow through 2018 driven by slowing Digital growth and faster legacy erosion as SaaS workloads move to the cloud. Schneider also expects outsourcing growth to slow in 2017 as bookings have declined recently and expects the multiple to come under pressure as growth in Digital and outsourcing slows.
04/03/17
04/03/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Acorda Therapeutics (ACOR) was downgraded to Neutral from Overweight at JPMorgan and to Neutral after Ampyra ruling at Janney Capital. 2. Under Armour (UA, UAA) downgraded to Underperform from Market Perform at FBR Capital with analyst Susan Anderson saying her channel checks and proprietary survey point to continued sales and margin pressure. Further, the checks show a price war is intensifying between Nike (NKE) and Under Armour following the latter's entrance into Kohl's (KSS). She believes Under Armour's apparel growth and margins may be worse than expected. 3. Priceline (PCLN) downgraded to Neutral from Buy at MoffettNathanson with analyst Perry Gold saying Priceline's valuation is no longer attractive, Trump's travel ban could have a negative impact, paid search should deteriorate further and comps get more difficult versus the strong 2016, and sees increasing FX headwinds. 4. Accenture (ACN) downgraded to Sell from Neutral at Goldman with analyst James Schneider telling investors he expects consulting growth to slow through 2018 driven by slowing Digital growth and faster legacy erosion as SaaS workloads move to the cloud. Schneider also expects outsourcing growth to slow in 2017 as bookings have declined recently and expects the multiple to come under pressure as growth in Digital and outsourcing slows. 5. TRC Companies (TRR) downgraded to Neutral from Buy at Sidoti. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/04/17
BARD
04/04/17
NO CHANGE
Target $132
BARD
Neutral
Accenture risk/reward improving, says Baird
Baird analyst David Koning said he is warming up to Accenture shares, citing an improved risk/reward following its acquisition of Genfour, its recent underperformance, and upcoming easing comps and improving end-markets. Koning maintained his Neutral rating and $132 price target on Accenture shares.
04/13/17
BARD
04/13/17
NO CHANGE
Target $132
BARD
Neutral
Baird warming up to Accenture shares
Baird analyst Davis Koning said he is warming up to Accenture shares, citing the improving risk/reward, recent underperformance, easing comps and its acquisition of BeesPath's ClosingBridge platform. Koning maintained his Neutral rating and $132 price target on Accenture shares.

TODAY'S FREE FLY STORIES

RDCM

Radcom

$19.65

0.25 (1.29%)

05:52
05/22/18
05/22
05:52
05/22/18
05:52
Conference/Events
Radcom management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 24

    May

  • 29

    May

INFO

IHS Markit

$51.60

0.13 (0.25%)

05:52
05/22/18
05/22
05:52
05/22/18
05:52
Upgrade
IHS Markit rating change  »

IHS Markit upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FITB

Fifth Third

$30.89

-2.66 (-7.93%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Upgrade
Fifth Third rating change  »

Fifth Third upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTM

Quantum

$3.62

-0.06 (-1.63%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Conference/Events
Quantum management to meet with Lake Street »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

FITB

Fifth Third

$30.89

-2.66 (-7.93%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Upgrade
Fifth Third rating change  »

Fifth Third upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTEX

OpenText

$34.10

0.1 (0.29%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Conference/Events
OpenText management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

NVEE

NV5 Global

$60.60

0.6 (1.00%)

05:50
05/22/18
05/22
05:50
05/22/18
05:50
Conference/Events
NV5 Global management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 09

    Jun

  • 12

    Jun

  • 13

    Jun

M

Macy's

$34.60

0.63 (1.85%)

05:49
05/22/18
05/22
05:49
05/22/18
05:49
Upgrade
Macy's rating change  »

Macy's upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCR

NCR Corp.

$31.30

0.11 (0.35%)

05:49
05/22/18
05/22
05:49
05/22/18
05:49
Conference/Events
NCR Corp. management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

ONCE

Spark Therapeutics

$73.03

-3.69 (-4.81%)

, PFE

Pfizer

$35.79

0.15 (0.42%)

05:44
05/22/18
05/22
05:44
05/22/18
05:44
Hot Stocks
Spark Therapeutics, Pfizer announce data SPK-9001 ongoing Phase 1/2 trial »

Spark Therapeutics (ONCE)…

ONCE

Spark Therapeutics

$73.03

-3.69 (-4.81%)

PFE

Pfizer

$35.79

0.15 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

FMC

FMC Corporation

$91.30

-0.22 (-0.24%)

05:41
05/22/18
05/22
05:41
05/22/18
05:41
Hot Stocks
FMC Corporation awarded contract for two fertilizer plants in India »

TechnipFMC, in consortium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$5.17

0.05 (0.98%)

05:40
05/22/18
05/22
05:40
05/22/18
05:40
Hot Stocks
Sprint partners with Scopeworker on multi-billion dollar 5G depoloyment »

Scopeworker announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSHD

Goosehead Insurance

$16.19

0.12 (0.75%)

05:39
05/22/18
05/22
05:39
05/22/18
05:39
Initiation
Goosehead Insurance initiated  »

Goosehead Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$20.00

0.14 (0.70%)

05:38
05/22/18
05/22
05:38
05/22/18
05:38
Initiation
Smartsheet initiated  »

Smartsheet initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

VLRS

Volaris

$5.42

-0.05 (-0.91%)

05:19
05/22/18
05/22
05:19
05/22/18
05:19
Recommendations
Volaris analyst commentary  »

Volaris price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAX

Baxter

$72.08

1.4603 (2.07%)

05:16
05/22/18
05/22
05:16
05/22/18
05:16
Recommendations
Baxter analyst commentary  »

Baxter buybacks should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOCU

DocuSign

$43.06

-1.73 (-3.86%)

05:08
05/22/18
05/22
05:08
05/22/18
05:08
Initiation
DocuSign initiated  »

DocuSign initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

AROC

Archrock

$12.30

0.35 (2.93%)

05:07
05/22/18
05/22
05:07
05/22/18
05:07
Recommendations
Archrock analyst commentary  »

Archrock added to Alpha…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$23.60

-0.065 (-0.27%)

05:05
05/22/18
05/22
05:05
05/22/18
05:05
Recommendations
Pure Storage analyst commentary  »

Pure Storage weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 07

    Jun

  • 12

    Jun

  • 10

    Jul

DOCU

DocuSign

$43.06

-1.73 (-3.86%)

05:02
05/22/18
05/22
05:02
05/22/18
05:02
Initiation
DocuSign initiated  »

DocuSign initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

SSL

Sasol

$37.93

0.05 (0.13%)

05:00
05/22/18
05/22
05:00
05/22/18
05:00
Downgrade
Sasol rating change  »

Sasol downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSHD

Goosehead Insurance

$16.19

0.12 (0.75%)

04:58
05/22/18
05/22
04:58
05/22/18
04:58
Initiation
Goosehead Insurance initiated  »

Goosehead Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXTR

Extreme Networks

$9.16

-0.02 (-0.22%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Extreme Networks management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

  • 29

    May

ALG

Alamo Group

$100.36

1.34 (1.35%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Alamo Group management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

ALNA

Allena Pharmaceuticals

$15.99

-0.01 (-0.06%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Allena Pharmaceuticals management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.